<DOC>
	<DOCNO>NCT01468090</DOCNO>
	<brief_summary>The aim study 7-year follow-up consecutive inception cohort 562 adult child diagnose registered inflammatory bowel disease 2003-04 order evaluate consequence biological therapy treatment IBD . The cohort establish implementation biological agent treatment IBD investigator hypothesis ) Severe disease course IBD predict phenotypic presentation serological , genetic , clinical endoscopic characteristic use guidance selection treatment strategy b ) Introduction biological treatment change course disease IBD reduce need surgical procedure . Methods : Medical record review register use medication , flare ups ( medical surgical ) hospital admission . Diagnosis , disease localization behavior evaluate . At outpatient visit patient get clinical examination , blood faeces collect biobank patient offer endoscopical examination . The Montreal classification , The Harvey &amp; Bradshaw 's activity index ( CD ) SCAAI score ( UC ) use describe disease localization , extent , behavior severity . An electronic database establish use process data .</brief_summary>
	<brief_title>Disease Course IBD Cohort Era Biological Treatment</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>All patient wil follow diagnosis reassess . NonIBD ( reassess diagnosis )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Inflammatory bowel disease</keyword>
	<keyword>Crohn 's disease</keyword>
	<keyword>Ulcerative colitis</keyword>
	<keyword>Disease course</keyword>
	<keyword>Phenotype</keyword>
	<keyword>Biological treatment</keyword>
</DOC>